Meningitis vaccine can now be used in a larger population

October 22, 2007

Menactra, a meningitis vaccine from sanofi pasteur, can now be used in kids from two to 10.

The meningitis vaccine, Menactra (sanofi pasteur), is now approved for kids from two to 10 in age. Previously, the vaccine was approved for those from 11 to 55 years old. With this approval, there are now two vaccines for individuals from two on up—Menactra and Menomune, both from the same manufacturer. CDC's advisory committee on immunization practices recommends that kids from two to 10 be given a meningitis shot if they are at high risk, such as those with certain infections or spleen problems or those who have to travel abroad in areas where this disease is common. Menactra is contraindicated in individuals who have come down with Guillain-Barré syndrome.

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.